期刊
CANCER LETTERS
卷 345, 期 2, 页码 153-156出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.08.025
关键词
Gastrointestinal cancer; Inflammation; NF-kappa B; STAT3; TLRs
类别
资金
- National Health and Medical Research Council of Australia
- Association for International Cancer Research (UK)
- Victorian Government of Australia
- Japan Society for the Promotion of Science (JSPS)
Gastrointestinal cancers collectively rank as the most lethal cancers worldwide, and are strongly linked with chronic inflammation. Despite advances over the last decade into our understanding of the etiology of these malignancies, both from a host perspective and with respect to environmental factors, current treatment strategies comprising surgery, chemotherapy and/or radiotherapy are still associated with unacceptably poor patient survival rates. Accordingly, there is a pressing need to identify new molecular targets which can underpin the development of next-generation treatment strategies to improve patient outcomes, and serve as biomarkers for early disease detection. In this review we provide an updated discussion on the identity of such candidate molecules, with a focus on innate immune system regulators within the gastrointestinal mucosal epithelium which promote inflammation and tumorigenesis. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据